Nutanix is trading 5.74% up at $72.51 as investors continued reacting to its August 26 fiscal 2026 results, which exceeded Wall Street expectations and included higher fiscal 2027 sales and margin guidance.
- Needham raised its target to $85, while Piper Sandler lifted its target to $75 and maintained positive ratings.
- The broader market is weaker, making the company-specific earnings response the most likely driver.